EMBC Stock Analysis: Buy, Sell, or Hold?
EMBC - Embecta Corp. Common Stock
$3.29
0.04 (1.23%)
▲
5d:
+1.23%
30d:
+6.13%
90d:
-64.04%
BUY
HIGH Confidence
Analysis Updated: Jul 24, 2026 12:00 AM ET
Earnings: Aug 14, 2026
18d
Get Alerted When EMBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: EMBC appears deeply undervalued. Market expects -14.2% annual earnings decline despite 83% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: EMBC appears deeply undervalued. Market expects -14.2% annual earnings decline despite 83% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.20
Based on 6.7% avg growth
INTRINSIC VALUE TODAY
$4.47
26.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EMBC is currently trading at $3.29, which is considered fair relative to its 30-day fair value range of $3.11 to $3.35. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.9) compared to its historical average (3.0). Remarkably, the market is currently pricing in an annual earnings decline of 14.2% over the next few years. This pessimistic expectation contrasts with the company's recent 82.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, EMBC is in a strong downtrend. Immediate support is located at $3.07, while resistance sits at $3.47.
Market Sentiment: EMBC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+21.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EMBC is in a strong downtrend. Immediate support is located at $3.07, while resistance sits at $3.47.
Market Sentiment: EMBC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+21.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.11 -
$3.35
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.6% below Wall St target ($4.00)
Trading Range Analysis
30-Day Trading Range
$3.11 -
$3.35
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.07
Resistance Level
$3.47
Current Trend
Strong Downtrend
Technical data as of
Jul 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.89
Wall Street Target
$4.00
(+21.6%)
Revenue Growth (YoY)
-14.4%
Earnings Growth (YoY)
82.7%
Profit Margin
10.7%
Valuation Discount vs History
-14.2% cheaper
PE vs Historical
1.9 vs 3.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.2%
(market-implied from PE analysis)
1-Year Target
$2.96
(-10%)
2-Year Target
$2.66
(-19%)
3-Year Target
$2.40
(-27%)
3-Yr Target (if PE normalizes)
(PE: 2→3)
$3.81
(+16%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.8, Growth: 9.3%)
$47.23
(+1336%)
Base:
(SPY PE: 1.9, Growth: 9.3%)
$4.29
(+30%)
Bear:
(PE: 1.6, Growth: 9.3%)
$3.65
(+11%)
📈
Valuation based on Current Earnings
Trailing PE: 1.72 | Current EPS (TTM): $1.89
Bull Case
$3.29
(0%)
Analyst growth -7.9%, PE expands to 1.9
Base Case
$2.99
(-9%)
Market implied -7.9%, PE stable at 1.7
Bear Case
$2.21
(-33%)
Severe decline -20.0%, PE contracts to 1.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.9 to 3.0
Stabilization Target:
$5.22
(+58.7%)
PE Expansion Potential:
+58.7%
Share & Embed Analysis
Last updated: July 26, 2026 5:28 AM ET
Data refreshes hourly during market hours. Next update: 6:28 AM
Data refreshes hourly during market hours. Next update: 6:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EMBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$504 | 44 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 46 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$178 | 54 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$382 | 52 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$249 | 47 HOLD |
